4-S-(propionic acid)sulfidocyclophosphamide: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 129829 |
MeSH ID | M0090852 |
Synonym |
---|
propanoic acid, 3-((2-bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin-4-yl)thio)-, p-oxide |
4-s-(propionic acid)sulfidocyclophosphamide |
4-s-(propionic acid)-sulfidocyclophosphamide |
2h-1,3,2-oxazaphosphorine, tetrahydro-2-(bis(2-chloroethyl)amino)-4-((2-carboxyethyl)thio)-, 2-oxide |
3-({2-[bis(2-chloroethyl)amino]-2-oxido-1,3,2-oxazaphosphinan-4-yl}sulfanyl)propanoic acid |
70396-87-1 |
3-({2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2lambda~5~-oxazaphosphinan-4-yl}sulfanyl)propanoic acid |
DTXSID30990602 |
Excerpt | Reference | Relevance |
---|---|---|
"5 mM was only slightly toxic to hypoxic L1210 cells and allowed a greater than 90% survival following a 2-hr exposure." | ( The effect of misonidazole on the cytotoxicity and DNA cross-linking activity of an activated sulfidocyclophosphamide in hypoxic mouse leukemia cells. Erickson, LC; McManus, ME; Ramonas, LM, 1982) | 0.26 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.94) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (14.29%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |